## Biochemical Mechanisms of Alcoholic Liver Injury ### Overview of Ethanol Metabolism **Key Point:** Ethanol metabolism in the liver generates toxic metabolites and oxidative stress, triggering a cascade of hepatocyte injury, inflammation, and fibrosis. Understanding the enzymatic pathways and their consequences is essential for NEET PG. ### Primary Metabolic Pathway 1. **Alcohol Dehydrogenase (ADH)** — Main route (90% of ethanol) - Ethanol → Acetaldehyde (via ADH) - Acetaldehyde → Acetate (via aldehyde dehydrogenase, ALDH) - Both reactions generate NADH, creating a high NADH/NAD+ ratio 2. **CYP2E1** — Microsomal ethanol-oxidizing system (MEOS) - Becomes increasingly important at high ethanol concentrations - Generates reactive oxygen species (ROS) as a byproduct - Induces its own expression with chronic alcohol use 3. **Catalase** — Minor pathway (< 10%) - Peroxisomal enzyme; minimal contribution **High-Yield:** At high alcohol doses, CYP2E1 becomes the dominant pathway, explaining why chronic alcoholics have amplified oxidative stress and accelerated liver disease. ### Mechanisms of Hepatocyte Injury ```mermaid flowchart TD A[Ethanol ingestion]:::outcome --> B[ADH + CYP2E1 metabolism]:::action B --> C1[Acetaldehyde accumulation]:::outcome B --> C2[NADH accumulation]:::outcome B --> C3[ROS generation]:::outcome C1 --> D1[Protein adduct formation<br/>Immunogenic]:::action C2 --> D2[Fatty acid oxidation ↓<br/>Lipogenesis ↑<br/>Steatosis]:::action C3 --> D3[Oxidative stress<br/>Lipid peroxidation<br/>Mitochondrial damage]:::action D1 --> E[Autoimmune response<br/>Anti-ADH antibodies]:::outcome D2 --> F[Hepatocyte steatosis]:::outcome D3 --> G[Stellate cell activation<br/>Fibrosis]:::outcome C1 --> H[Gut barrier dysfunction<br/>Endotoxemia]:::action H --> I[TLR4 activation on Kupffer cells]:::action I --> J[TNF-α, IL-6 release<br/>Inflammation perpetuation]:::outcome ``` ### Detailed Mechanisms #### 1. Acetaldehyde Toxicity ✓ - Acetaldehyde is highly reactive and toxic - Forms protein adducts (acetaldehyde-protein conjugates) - These adducts are immunogenic → trigger antibody formation (anti-ADH, anti-acetaldehyde) - Contributes to both direct hepatocyte injury and immune-mediated damage - Inhibits mitochondrial function and protein synthesis **Clinical Pearl:** Disulfiram (Antabuse) works by inhibiting ALDH, causing acetaldehyde accumulation and an aversive reaction to alcohol. #### 2. NADH Accumulation ✗ — THE TRAP Option 2 contains a **critical error**: it states that oxidative stress arises from "NADH accumulation." This is biochemically incorrect. **Key Point:** NADH accumulation does NOT directly cause oxidative stress. Rather: - High NADH/NAD+ ratio **inhibits** fatty acid oxidation → steatosis - High NADH/NAD+ ratio promotes lactate formation → lactic acidosis - High NADH/NAD+ ratio impairs gluconeogenesis → hypoglycemia **Oxidative stress** in alcoholic liver disease arises from: - **CYP2E1-generated ROS** (superoxide, hydrogen peroxide, hydroxyl radicals) - **Mitochondrial dysfunction** (impaired electron transport) - **Lipid peroxidation** from accumulated fatty acids - **Iron overload** (alcohol increases iron absorption) NADH accumulation is a metabolic consequence of ethanol metabolism but is NOT the source of oxidative stress. The confusion likely arises because both NADH and ROS are byproducts of metabolism, but they operate via different mechanisms. #### 3. Endotoxemia & TLR4 Activation ✓ - Chronic alcohol increases intestinal permeability ("leaky gut") - Bacterial lipopolysaccharide (LPS/endotoxin) translocates into portal blood - LPS binds TLR4 on Kupffer cells (hepatic macrophages) - TLR4 activation → NF-κB signaling → TNF-α, IL-6, IL-8 release - TNF-α perpetuates hepatocyte apoptosis and inflammation - Contributes to progression from steatosis → steatohepatitis → cirrhosis **High-Yield:** Endotoxemia is a major driver of the inflammatory phase (alcoholic hepatitis) and explains why antibiotics and anti-TNF therapies show some benefit in severe alcoholic hepatitis. #### 4. Stellate Cell Activation & Fibrosis ✓ - ROS and acetaldehyde activate hepatic stellate cells (myofibroblasts) - Stellate cells produce collagen types I and III - TGF-β signaling (from Kupffer cells and damaged hepatocytes) amplifies stellate cell activation - Results in progressive fibrosis → cirrhosis - Pericentral (Zone 3) distribution due to high CYP2E1 expression in Zone 3 ### Summary Table: Mechanisms of Injury | Mechanism | Cause | Effect | |-----------|-------|--------| | **Acetaldehyde toxicity** | ADH metabolism | Protein adducts, autoimmunity, mitochondrial damage | | **NADH accumulation** | ADH metabolism | Steatosis, lactic acidosis, hypoglycemia (NOT oxidative stress) | | **ROS generation** | CYP2E1 metabolism | Lipid peroxidation, mitochondrial injury, stellate cell activation | | **Endotoxemia** | Increased intestinal permeability | TLR4 activation, TNF-α release, inflammation | | **Stellate cell activation** | ROS + TGF-β + acetaldehyde | Fibrosis and cirrhosis | **Warning:** Do not confuse NADH accumulation (a metabolic consequence that impairs oxidation) with oxidative stress (ROS-mediated damage). They are distinct phenomena.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.